 OncoSec Medical Incorporated the Company or OncoSec Nasdaq: ONCS, a company developing late-stage intratumoral cancer immunotherapies, today announced the Company is set to join the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the US market opens on June 29th, according to a final list of additions posted June 15th. 